Skip to content

For investors
Customer support
Webstore
Document portal

Diagnostic areas
Products
Services
Resources
About us

Contact us

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Post-transplantation
One Lambda Devyser Accept cfDNA
One Lambda Devyser Chimerism NGS

Thalassemia
Devyser Thalassemia NGS
Devyser Thalassemia v2

Hereditary cancer
Devyser BRCA NGS
Devyser HBOC NGS
Devyser BRCA PALB2 NGS
Devyser LynchFAP

Fetal RHD screening NIPT
Devyser RHD

Cystic fibrosis
Devyser CFTR Core
Devyser CFTR 68
Devyser CFTR NGS
Devyser CFTR Italia

Cardiovascular diseases
Devyser Thrombophilia
Devyser FH NGS
Devyser HFE
Devyser CVD

Male infertility
Devyser AZF Extension
Devyser AZF v2

Rapid aneuploidy analysis
Devyser Compact
Devyser Complete
Devyser Extend
Devyser Resolution 13
Devyser Resolution 18
Devyser Resolution 21
Devyser Resolution XY

Software
Advyser Solid organs
Advyser Chimerism
Amplicon Suite

Accessories
560 sizer orange
DEV-5 Dye set
Devyser Index plate A
Devyser Index plate LB-A
Devyser library clean

Devyser Genomic Laboratories

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

Our company
Investors
Distributors
News and press
Career
Sustainability
Contact us

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products

Post-transplantation
- One Lambda Devyser Accept cfDNA
- One Lambda Devyser Chimerism NGS
Thalassemia
- Devyser Thalassemia NGS
- Devyser Thalassemia v2
Hereditary cancer
Fetal RHD screening NIPT
- Devyser RHD
Cystic fibrosis
Cardiovascular diseases
Male infertility
- Devyser AZF Extension
- Devyser AZF v2
Rapid aneuploidy analysis
Software
Accessories

Services

Devyser Genomic Laboratories

Resources

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Investors
Distributors
News and press
Career
Sustainability
Contact us

For investors
Customer support
Webstore
Document portal

The Devyser blog

Fetal RHD screening NIPT | January 17, 2024

Top performance at high-throughput: Devyser RHD maintains high sensitivity within an automated, high-throughput setting in Sahlgrenska University Hospital Study

Over the past decade, there has been a wealth of research investigating the ideal approach to RHD genotyping, to determine RhD incompatibility between mother and fetus, which is one of the main...

Find out more

Filter

Admin (4)

Devyser Genomic Laboratories signs first commercial agreement

Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first...

Devyser wins tender for cystic fibrosis in Italy

Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...

Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests

Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....

The utility of broader CFTR genotyping in cystic fibrosis populations

On October 26th, we hosted an insightful webinar by Prof. Milan Macek (M.D., DSc.), where he...

Devyser strengthens position in Italy - wins tender for cystic fibrosis

Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...

Devyser wins tender for non-invasive fetal RHD testing in Wales

Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...

Elevating laboratory workflow: NHS Scotland implemented Devyser FH NGS for improved speed and clinical precision

Meet Silvia Borras, a Development Lead and Clinical Scientist in Genetics and Molecular Pathology...

Devyser Diagnostics AB publishes quarterly report for July to September 2023

“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...

Bioiatriki - 15 years of reliable and rapid aneuploidy testing with Devyser Compact

Bioiatriki is a leading medical laboratory in Greece, providing a range of prenatal genetic testing...

Devyser IVDR certified

Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals

Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...

Revised guidelines for cystic fibrosis carrier screening: The American College of Medical Genetics and Genomics (ACMG) expands CFTR screening recommendations

The American College of Medical Genetics and Genomics (ACMG) has released an updated position...

Early detection of relapse and early therapeutic intervention: The benefits of Devyser NGS method for chimerism analysis

A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...

< 2 3 4 5 6 >

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products and services

Kits and reagents
Our services

Resources

Events & webinars
Knowledge hub
Whitepapers
Devyser blog
Calculator for Chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Contact us
Distributors
News and press
Career
Whistleblowing policy
Sustainability

Investors

Press releases
Reports

© Devyser 2025

Privacy policy | Legal terms | About cookies